Rapid Susceptibility Test for Staph Developed
The team at UC San Diego included infectious disease specialists in the School of Medicine, Victor Nizet, MD, and George Sakoulas, MD; two biologists in the Division of Biological Sciences, Kit and Joe Pogliano; and Diana Quach, a bioengineering graduate student.
Their paper, published online in EBioMedicine, outlines the method the researchers developed to test whether bacteria are treatable with traditional antibiotics or are drug resistant and need to be treated with newer antibiotics. The hope is that this approach will slow the emergence of resistant bacteria by limiting the newest drugs for the infections they are most needed for.
See Also: New Antibiotics Group Shows Promise Against Staph, MRSA
The team had previously developed a microscopy-based method that performs an autopsy on bacterial cells that shows how each cell died. They showed that this method can identify new antibiotics and help understand how these antibiotics work.
Kit Pogliano, a professor of biology at UC San Diego who headed the research team, said: "We tested to see if this method could be applied to antibiotic susceptibility testing. Surprisingly, we not only found that our method was able to accurately differentiate sensitive S. aureus strains from resistant MRSA strains, but that we were able to identify two subgroups of MRSA strains, one of which is susceptible to combinations of antibiotics that could be used in the hospital. We are excited by the accuracy and speed of this test, as well as by its unanticipated ability to identify these two types of MRSA infections, which would have been missed by other tests."
The advantages of examining single cells are its speed and the fact that this method does not rely on having any detailed understanding of the bacterium causing the infection, or of the genes that convey resistance, say the research team. As resistance to the drugs used to treat MRSA infections arises by several evolutionary pathways via different combinations of mutations, it could also provide rapid treatment information for newly emerging bacterial pathogens, such as that which caused the infections transmitted by endoscopes.
"When we combine careful culture conditions, cutting edge imaging methods and a detailed quantitative analysis, we can turn this simple approach into a reliable test," said Joe Pogliano, a professor of biology.
The researchers say their new method, which is being commercialised, has the potential to be applied to many different types of bacteria. "Our new method worked surprising well at rapidly detecting antibiotic resistant strains of S. aureus," said Diana Quach, a graduate student and lead author on the study. "We are now optimising it to provide a more accurate test for other types of antibiotic resistant bacteria, such as Pseudomonas aeruginosa."
Source: UC San Diego
Image credit: Wikimedia Commons
Published on : Tue, 2 Feb 2016
Print as PDF
NovaPort cannulas: The safe access to the vascular system. NovaPort® twin double lumen cannulas are specifically developed for veno-venous vascular access. NovaPort one single lumen cannulas are specifically developed for the percutaneous connection (KU)...
Medos hemofilters pro are used for efficient and gentle hemofiltration during extracorporal circulation.Medos hemofilters pro do not need to be pre-flushed and can be used immediately. This guarantees a safe and quick hemofiltration.
medos customized tubing sets have been individually designed, so that all customer requirements, depending on application and need can be realized. Furthermore tubing sets can be refined by rheoparin or x.eed coating. Customized and standard tubing sets...
17 critical parameters from a blood sample as small as 45 µL Not available in the US When the sample is small but your diagnostic needs are big, the ABL90 FLEX PLUS blood gas analyzer provides critical insights with a turnaround time of less than...